Bayer Allocates $2 Billion To Settle Future Roundup Cancer Claims

Bayer Allocates $2 Billion To Settle Future Roundup Cancer Claims

Monsanto’s parent company Bayer AG said it expects to pay $2 billion in a class settlement to resolve future claims that Roundup weedkiller causes cancer, increasing its original estimate of $1.25 billion.

The deal is part of a larger settlement the company announced in June to resolve claims in the sprawling multidistrict litigation in California federal court, which centers on allegations that glyphosate in the weedkiller Roundup made by Monsanto causes non-Hodgkin’s lymphoma.

“We are working in good faith to address the issues raised by the court to the satisfaction of the parties and need additional time to complete this process,” Bayer said in a statement. “These negotiations are confidential and therefore we cannot comment further at this time. Given the progress in the negotiations, we are taking additional provision in this quarter in part to cover the expected additional cost of the revised class plan which will take the cost of this program from $1.25 to approximately $2 billion.”

Bayer’s announcement comes more than a month after plaintiffs’ attorneys told the court they’d reached a “binding” agreement with Bayer following concerns that a $10 billion settlement announced in June fell through.

Representatives for the plaintiffs could not immediately be reached for comment.

Share

Litigation Updates

Roundup Lawsuit Update May 2022

May 20, 2022

May 20, 2022

Roundup Lawsuit Update May 2022

Bayer Reaches $2 Billion for Future Roundup Claims

February 3, 2021

February 3, 2021

Bayer Reaches $2 Billion for Future Roundup Claims

Bayer Allocates $2 Billion To Settle Future Roundup Cancer Claims

November 3, 2020

November 3, 2020

Bayer Allocates $2 Billion To Settle Future Roundup Cancer Claims

Monsanto Loses Cancer Liability Lawsuit in Roundup Appeal

September 20, 2020

September 20, 2020

Monsanto Loses Cancer Liability Lawsuit in Roundup Appeal

Judge Casts Doubt Over Settlement of Roundup Cancer Claims

July 7, 2020

July 7, 2020

Judge Casts Doubt Over Settlement of Roundup Cancer Claims

Jury Finds Monsanto Liable in Man’s Cancer, Awards $80 Million in Damages

March 27, 2019

March 27, 2019

Jury Finds Monsanto Liable in Man’s Cancer, Awards $80 Million in Damages

CLIENT REVIEWS

quotation
Tom Lewis

TorHoerman Law was responsible for handling a medical case for our family. I was extremely impressed with their professionalism and ability to react quickly. They also did a nice job keeping us updated with the case throughout the process. This was the first time experiencing a situation like this and Tor Hoerman law did an excellent job from start to finish.

quotation
Jordan Terry

TorHoerman Law is an extraordinary law firm – a firm that truly makes the client’s best interests the primary concern. Their team of personal injury lawyers are experienced, personable, and well versed in a range of litigation areas. They are supported by a dedicated team of staff that are as equally friendly and helpful. I would recommend TorHoerman Law for any personal injury litigation needs.

quotation
Dave Woodley

All of my questions were answered quickly and in a way I could understand. Steve and the entire staff were friendly and professional.

quotation
Jordan Butler

I highly recommend this law firm! The attorneys and staff at THL worked hard, communicated every step of the process, kept me well informed at all times, and exceeded all expectations! The staff is kind, considerate, professional, and very experienced. Look no further, call now!

quotation
Maddy Moeller

Top-notch, hardworking attorneys!

quotation
Karen Hersman

A wonderful and professional legal team. They helped me when I needed expert legal representation! Thank you TorHoerman Law!

quotation
Angel Truesdale

They contacted me the next day. Very nice people!

quotation
Paul Graegin

The firm went above and beyond. Thank you for everything.

THANK YOU FOR YOUR MESSAGE

One of our associates will follow up with you shortly